• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABO血型与血栓形成后综合征的风险

ABO blood group and the risk of post-thrombotic syndrome.

作者信息

Spiezia Luca, Campello Elena, Valle Fabio Dalla, Simion Chiara, Colpo Anna, Simioni Paolo

机构信息

Department of Medicine, Thrombotic and Hemorrhagic Diseases Unit, University of Padua Medical School, Via Giustiniani, 2, 35128, Padua, Italy.

出版信息

Ann Hematol. 2018 Jun;97(6):1057-1060. doi: 10.1007/s00277-018-3255-3. Epub 2018 Feb 1.

DOI:10.1007/s00277-018-3255-3
PMID:29387976
Abstract

Post-thrombotic syndrome (PTS) has been associated to DVT recurrence, increased FVIII, inflammatory biomarker plasma levels, and persistence of vein obstruction. These same features have also been widely reported in non-O blood type subjects. Our aim was to investigate the correlation between the incidence of PTS and ABO blood types. Consecutive patients referred to the Department of Medicine of University of Padua between January 2004 and January 2012 following the diagnosis of a first episode of proximal DVT were enrolled. The presence of PTS was assessed via the Villalta scale at predefined time points (3, 6, 12, 18, 24, 36 months). Hazard ratio (HR) for PTS development was calculated in non-O (exposed) vs O blood (unexposed) type patients. Out of 671 eligible patients, 606 were enrolled. Overall, 192 (31.7%) patients developed PTS: 142 (34.5%) non-O and 50 (25.6%) O blood type patients. Individuals with non-O blood group were associated with a significantly higher risk to develop PTS (HR 1.53, 95% CI, 1.05-2.24; p = 0.028) than O group. Non-O blood type might be a risk factor for the development of PTS.

摘要

血栓形成后综合征(PTS)与深静脉血栓形成(DVT)复发、因子VIII升高、炎症生物标志物血浆水平以及静脉阻塞持续存在有关。在非O血型受试者中也广泛报道了这些相同的特征。我们的目的是研究PTS发病率与ABO血型之间的相关性。纳入了2004年1月至2012年1月期间因首次诊断为近端DVT而转诊至帕多瓦大学医学系的连续患者。在预定时间点(3、6、12、18、24、36个月)通过Villalta量表评估PTS的存在情况。计算非O型(暴露)与O型血(未暴露)患者发生PTS的风险比(HR)。在671名符合条件的患者中,606名被纳入研究。总体而言,192名(31.7%)患者发生了PTS:142名(34.5%)非O型血和50名(25.6%)O型血患者。非O血型个体发生PTS的风险显著高于O型血个体(HR 1.53,95% CI,1.05 - 2.24;p = 0.028)。非O血型可能是PTS发生的一个危险因素。

相似文献

1
ABO blood group and the risk of post-thrombotic syndrome.ABO血型与血栓形成后综合征的风险
Ann Hematol. 2018 Jun;97(6):1057-1060. doi: 10.1007/s00277-018-3255-3. Epub 2018 Feb 1.
2
Risk Factors for Post-Thrombotic Syndrome in Patients With a First Proximal Deep Venous Thrombosis Treated With Direct Oral Anticoagulants.直接口服抗凝剂治疗的首次近端深静脉血栓形成患者发生血栓后综合征的危险因素。
Angiology. 2022 Aug;73(7):649-654. doi: 10.1177/00033197211070889. Epub 2022 Jan 6.
3
D-dimer, FVIII and thrombotic burden in the acute phase of deep vein thrombosis in relation to the risk of post-thrombotic syndrome.深静脉血栓形成急性期的D-二聚体、FVIII与血栓负荷与血栓后综合征风险的关系
Thromb Res. 2014 Aug;134(2):320-5. doi: 10.1016/j.thromres.2014.05.043. Epub 2014 Jun 8.
4
Effect of the anticoagulant therapy in the incidence of post-thrombotic syndrome and recurrent thromboembolism: Comparative study of enoxaparin versus coumarin.抗凝治疗对血栓形成后综合征发病率及复发性血栓栓塞的影响:依诺肝素与香豆素的对比研究。
J Vasc Surg. 2008 Oct;48(4):953-9. doi: 10.1016/j.jvs.2008.05.033. Epub 2008 Jul 18.
5
Markers of coagulation, fibrinolysis and inflammation in relation to post-thrombotic syndrome.凝血、纤溶和炎症标志物与血栓后综合征的关系。
J Thromb Haemost. 2012 Aug;10(8):1532-8. doi: 10.1111/j.1538-7836.2012.04798.x.
6
Prevention of recurrent venous thrombosis and post-thrombotic syndrome.预防复发性静脉血栓形成和血栓后综合征。
Minerva Cardioangiol. 2018 Jun;66(3):238-245. doi: 10.23736/S0026-4725.18.04618-2.
7
Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.长期升高的因子 VIII 水平与白细胞介素-6 水平相关,但与深静脉血栓形成患者的血栓后综合征无关。
Thromb Res. 2015 Mar;135(3):497-501. doi: 10.1016/j.thromres.2014.12.024. Epub 2014 Dec 31.
8
[Study of prognostic factors and prevalence of post-thrombotic syndrome in patients with deep vein thrombosis in Spain].[西班牙深静脉血栓形成患者的预后因素及血栓形成后综合征患病率研究]
Med Clin (Barc). 2016 Jan 15;146(2):49-54. doi: 10.1016/j.medcli.2015.04.030. Epub 2015 Jul 18.
9
Individually tailored duration of elastic compression therapy in relation to incidence of the postthrombotic syndrome.个体化弹力压迫治疗持续时间与血栓后综合征发生率的关系。
J Vasc Surg. 2010 Jul;52(1):132-8. doi: 10.1016/j.jvs.2010.01.089. Epub 2010 Apr 10.
10
Plasma MMP and TIMP evaluation in patients with deep venous thrombosis: could they have a predictive role in the development of post-thrombotic syndrome?深静脉血栓形成患者血浆基质金属蛋白酶(MMP)和组织金属蛋白酶抑制剂(TIMP)的评估:它们对血栓后综合征的发生是否具有预测作用?
Int Wound J. 2016 Dec;13(6):1237-1245. doi: 10.1111/iwj.12489. Epub 2015 Sep 24.

引用本文的文献

1
Analysis of risk factors for lower extremity DVT following robot-assisted radical prostatectomy and nursing intervention strategies: a single centre retrospective cohort study.机器人辅助根治性前列腺切除术后下肢深静脉血栓形成的危险因素分析及护理干预策略:一项单中心回顾性队列研究
J Robot Surg. 2025 Sep 16;19(1):611. doi: 10.1007/s11701-025-02784-6.
2
Correlation between ABO blood type and lower extremity deep vein thrombosis in elderly patients following hip fracture.老年髋部骨折患者ABO血型与下肢深静脉血栓形成的相关性
Am J Transl Res. 2024 Jun 15;16(6):2654-2661. doi: 10.62347/WKYA9182. eCollection 2024.
3
Role of von Willebrand factor in venous thromboembolic disease.
血管性血友病因子在静脉血栓栓塞性疾病中的作用。
JVS Vasc Sci. 2021 Oct 7;3:17-29. doi: 10.1016/j.jvssci.2021.08.002. eCollection 2022.
4
Upper Extremity Superficial Vein Thromboses Presenting as Acute Neck Pain in a Young and Healthy Male: A Case Report.年轻健康男性上肢浅静脉血栓形成表现为急性颈部疼痛:一例报告
Int J Sports Phys Ther. 2021 Jun 1;16(3):854-861. doi: 10.26603/001c.23429.
5
Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation.血流依赖性血栓形成中凝血和抗凝途径的血小板预激活相互作用。
Sci Rep. 2020 Jul 17;10(1):11910. doi: 10.1038/s41598-020-68438-9.